Immunotherapies for Life

4

SEC Filing Details

Document Details

Form
Filing Date
Sep 3, 2019
Document Date
Aug 29, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Y-mAbs Therapeutics, Inc.
Issuer
Y-mAbs Therapeutics, Inc.
Filer
Wedell-Wedellsborg Johan